Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Dorina, Cultrera"'
Autor:
Dorina Cultrera, Sergio Cabibbo
Publikováno v:
European Journal of Case Reports in Internal Medicine (2022)
Introduction: Severe haemophilia A is characterized by serious factor VIII deficiency (biological activity
Externí odkaz:
https://doaj.org/article/4b51eeb3a50b433b8b37ae3f6cc8152e
Autor:
Annarita Tagliaferri, Angelo Claudio Molinari, Flora Peyvandi, Antonio Coppola, Francesco Demartis, Chiara Biasoli, Alessandra Borchiellini, Dorina Cultrera, Raimondo De Cristofaro, Filomena Daniele, Paola Giordano, Emanuela Marchesini, Maurizio Margaglione, Renato Marino, Berardino Pollio, Paolo Radossi, Cristina Santoro, Rita Carlotta Santoro, Sergio Siragusa, Gianluca Sottilotta, Alberto Tosetto, Lydia Piscitelli, Maria Rosaria Villa, Ezio Zanon, Adele Finardi, Irene Schiavetti, Daniella Vaccari, Giancarlo Castaman
Publikováno v:
Haemophilia. 29:135-144
Introduction: Factor IX replacement therapy is used for treatment and prophylaxis of bleeding in haemophilia B. rIX-FP is an extended half-life albumin-fusion protein, which, in clinical studies, has demonstrated prolonged dosing intervals up to 21 d
Autor:
Dorina Cultrera, Raimondo De Cristofaro, Paola Giordano, Silvia Linari, Silvia Macchi, Renato Marino, Angelo Claudio Molinari, Angiola Rocino, Cristina Santoro, Piercarla Schinco, Sergio Siragusa, Giuseppe Tagariello, Annarita Tagliaferri, Ezio Zanon, Massimo Morfini
Publikováno v:
Reports, Vol 3, Iss 1, p 3 (2020)
This study aimed to identify the characteristics of patients with hemophilia B eligible for once-weekly treatment with Nonacog alfa. Methods: A survey was conducted in 14 Hemophilia (HCs) of Italy. These centers were given a questionnaire consisting
Externí odkaz:
https://doaj.org/article/ef7cafac02824b77a8a6385ee0114fa9
Autor:
Giancarlo Castaman, Alessandra Borchiellini, Antonio Coppola, Dorina Cultrera, Renato Marino, Augusto B. Federici, Anna Chiara Giuffrida, Emanuela Marchesini, Angelo Claudio Molinari, Siboni Simona Maria, Ezio Zanon
Publikováno v:
European journal of haematologyREFERENCES. 109(2)
The present review aims to summarize the state-of-the-art von Willebrand disease (VWD) treatment focusing on specific clinical settings (obstetrics, surgery, long-term prophylaxis and comorbidities) as well as on the use of a Von Willebrand factor (V
Autor:
Sergio Cabibbo, Dorina Cultrera
Publikováno v:
European journal of case reports in internal medicine. 9(7)
Introduction: Severe haemophilia A is characterized by serious factor VIII deficiency (biological activity
Autor:
Alessio Branchini, Massimo Morfini, Barbara Lunghi, Donata Belvini, Paolo Radossi, Loredana Bury, Maria Luisa Serino, Paola Giordano, Dorina Cultrera, Angelo Claudio Molinari, Mariasanta Napolitano, Elisabetta Bigagli, Giancarlo Castaman, Mirko Pinotti, Francesco Bernardi, Paola Agostini, Chiara Biasioli, Teresa Maria Caimi, Filomena Daniele, Alfredo Dragani, Donato Gemmati, Paolo Gresele, Silvia Linari, Gina Rossetti, Cristina Santoro, Rita Santoro, Gianluca Sottilotta, Johanna Svahn
Publikováno v:
Journal of thrombosis and haemostasis : JTH. 20(1)
Background Circulating dysfunctional factor IX (FIX) might modulate distribution of infused FIX in hemophilia B (HB) patients. Recurrent substitutions at FIX activation sites (R191-R226, >300 patients) are associated with variable FIX activity and an
Autor:
Elena Santagostino, Eleonora Russo, Giovanni Di Minno, Massimo Morfini, Erminia Baldacci, Dorina Cultrera, Cosimo Ettorre, Cristiano Gallucci
Publikováno v:
Patient Preference and Adherence. 13:233-240
Background FuseNGO is a relatively new device consisting of a prefilled dual-chamber syringe (DCS) that was recently introduced for the reconstitution of recombinant factor VIII. Herein, the DCS device was assessed using five questionnaires with the
Autor:
Mariasanta Napolitano, Renato Marino, Erminia Baldacci, Antonella Coluccia, Dorina Cultrera, Matteo Luciani, Samantha Pasca, Lisa Pieri, Irene Ricca, Giovanni Barillari, Cosimo Ettorre, Silvia Linari, Federica Valeri, Sergio Siragusa, Angiola Rocino
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3658::dd603f90bc251406aac30db6e4da75e9
http://hdl.handle.net/10447/340035
http://hdl.handle.net/10447/340035
Autor:
Annarita Tagliaferri, Cristina Santoro, Sergio Siragusa, Silvia Macchi, Raimondo De Cristofaro, Angiola Rocino, Renato Marino, Giuseppe Tagariello, Paola Giordano, Ezio Zanon, Silvia Linari, Angelo Claudio Molinari, Piercarla Schinco, Dorina Cultrera, Massimo Morfini
Publikováno v:
Reports, Vol 3, Iss 1, p 3 (2020)
This study aimed to identify the characteristics of patients with hemophilia B eligible for once-weekly treatment with Nonacog alfa. Methods: A survey was conducted in 14 Hemophilia (HCs) of Italy. These centers were given a questionnaire consisting
Autor:
Branchini, Alessio, Massimo, Morfini, Paolo, Gresele, Paolo, Radossi, Donata, Belvini, Roberta, Salviato, Angelo Claudio Molinari, Serino, Maria Luisa, Gemmati, Donato, Chiara, Biasoli, Dorina, Cultrera, Cristina, Santoro, Rita, Santoro, Mariasanta, Napolitano, Pinotti, Mirko, Giancarlo, Castaman, Bernardi, Francesco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3709::4f87b33a7fa37e7c1c25bd0984617f7e
http://hdl.handle.net/11392/2434337
http://hdl.handle.net/11392/2434337